|
SSR3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.28839999999653E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.942000E-03 |
| Normal-vs-Stage2 |
5.639800E-02 |
| Normal-vs-Stage3 |
1.674040E-02 |
| Normal-vs-Stage4 |
1.352230E-04 |
| Stage1-vs-Stage2 |
5.810800E-01 |
| Stage1-vs-Stage3 |
5.434000E-01 |
| Stage1-vs-Stage4 |
1.559780E-02 |
| Stage2-vs-Stage3 |
9.406600E-01 |
| Stage2-vs-Stage4 |
1.897230E-01 |
| Stage3-vs-Stage4 |
1.007360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.87509999996605E-06 |
| Normal-vs-AfricanAmerican |
6.613700E-02 |
| Normal-vs-Asian |
3.821400E-01 |
| Caucasian-vs-AfricanAmerican |
2.5365999967164E-08 |
| Caucasian-vs-Asian |
8.125800E-01 |
| AfricanAmerican-vs-Asian |
5.480500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.803270E-04 |
| Normal-vs-Female |
1.142810E-03 |
| Male-vs-Female |
5.752000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.392990E-01 |
| Normal-vs-Age(41-60Yrs) |
2.537700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.998330E-04 |
| Normal-vs-Age(81-100Yrs) |
2.979200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.705000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.176400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.374800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.200600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.905200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.496800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.725400E-01 |
| Normal-vs-Grade 2 |
4.599200E-03 |
| Normal-vs-Grade 3 |
1.003410E-03 |
| Normal-vs-Grade 4 |
2.045900E-04 |
| Grade 1-vs-Grade 2 |
4.016100E-02 |
| Grade 1-vs-Grade 3 |
1.953570E-02 |
| Grade 1-vs-Grade 4 |
1.279530E-03 |
| Grade 2-vs-Grade 3 |
5.604200E-01 |
| Grade 2-vs-Grade 4 |
3.242400E-02 |
| Grade 3-vs-Grade 4 |
5.705800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.235700E-04 |
| Normal-vs-ccB subtype |
7.772200E-04 |
| ccA subtype-vs-ccB subtype |
5.723600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.805900E-04 |
| Normal-vs-N1 |
5.230200E-02 |
| N0-vs-N1 |
2.190600E-01 |
|
|
